Overview
Status
Active
Registry date
2019-03-08
Share capital
17,500.00 PLN
Registered address
ul. Jerzego Samuela Bandtkiego 19, 30-129 Kraków, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 462 days for 2023).
- 2025not filed
- 202420/10/2025
- 202320/10/2025
- 202216/06/2023
- 202117/10/2022
- 202007/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Voivodeship · Małopolskie28,204 / 46,033
Top 61%
Country · Poland307,945 / 495,850
Top 62%
Results vs industry
Revenue
This companyUSD 73.93kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -93.54kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 160.56kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 505.78kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Magdalena Anna Pieprzyk – President of the Management Board
Jerzy Grzybek – Attorney-in-fact
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Anna Pieprzykage 40 | 140 | $1,890.87 | 40% |
Donald Piotr Piotrowskiage 65 | 35 | $472.72 | 10% |
Katarzyna Anastazja Sermak Jamróz | 70 | $945.43 | 20% |
Łukasz Maciej Stupkaage 36 | 105 | $1,418.15 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $1,269,896.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 19, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $32,989$32,989 | Marszałek Małopolski | |
| Aug 4, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,128$5,128 | Uniwersytet Jagielloński | |
| Feb 27, 2020 | Aid for research and development projects: industrial research | $686.4K$686,419 | Marszałek Małopolski |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-19 | Development of a method for producing and using hydrogel as a carrier for oral delivery of drugs, peptides and proteins | $32,989$32,989 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 | |
| 2020-02-27 | Development of a line of medical products based on nanogel, with properties ranging from skin care to therapeutic effects that soothe skin inflammation | $1.2M$1,218,756 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
Change history
| Date | Event | |
|---|---|---|
| 2024-05-16 | Share capital increase (5,000.00 PLN → 17,500.00 PLN) | |
| 2021-02-12 | Name change (Biopharm4m → Wellnanopharm) | |
| 2020-10-14 | Address change (Ul. Józefa Piłsudskiego 23, 32-050, Skawina → Ul. Jerzego Samuela Bandtkiego 19, 30-129, Kraków) | |
| 2020-09-30 | Name change (Wellno Pharma Polska → Biopharm4m) | |
| 2019-03-08 | Entered in the register |
FAQ
The main business activity of Wellnanopharm focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on March 8, 2019.
The headquarters is located at: ul. Jerzego Samuela Bandtkiego 19, 30-129 Kraków.
The share capital of the company is PLN 17,500 (approx. $4,727).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $73,927, representing a decrease of 60.4% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $93,538. For comparison, in 2023 the loss was $23,631, meaning the company increased its loss by 275.9%.
The largest operating cost category falls under depreciation and amortization. This category amounted to $108,168 in 2024, representing 67% of all operating expenses.
Last updated: 2026-04-11
